Learn how we’re changing the world of medicine. Discover career opportunities, our product pipeline, and browse media resources. Meet Moderna.

Moderna initiates first-in-human dosing for mRNA-1653, a combination vaccine with the potential to protect against more than one disease–human metapneumovirus (hMPV virus) and parainfluenza virus.

Our Mindsets Alongside our Values, our Mindsets allow us to overcome challenges together. We are working to build the best possible version of Moderna 20 years from now. These Mindsets are tools …

Find contact information, important phone numbers and addresses to Moderna head.

Track the development of Moderna’s mRNA medicines. From preclinical development to commercial phase.

In addition to mRNA vaccines, Moderna is working on other applications of potential mRNA therapeutics that could help people with cancer, metabolic diseases and more.

Join Moderna as we pursue the uncharted reaches of possibility and make your mark on the future of medicine.

Resources for journalists and media members. The latest press releases by Moderna.

Nov 6, 2025 · Innovation Incubator New venture labs Terms of Use Site Map Privacy Policy Contact Moderna © 2025 Moderna, Inc.

Explore mRNAs as Medicines, a three-module course designed by experts at Moderna that offers a comprehensive understanding of mRNA medicines, how they work and their potential applications.